Remove 2018 Remove Clinic Remove Diabetes Remove Diagnose
article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018. Experts even say the eye is an ideal place to start for the first clinical use of CRISPR. The Stanford Artificial Retina Project shows great promises.

Diabetes 105
article thumbnail

Higher Dietary Inflammatory Index Tied to Elevated CHD Risk

Physician's Weekly

Independent Association The study involved analysis of data from 43,842 adults in the National Health and Nutrition Examination Survey (NHANES, 1999-2018). had diabetes. A total of 1,842 participants reported physician-diagnosed CHD, and the mean DII score was 1.33. The cohort’s mean age was 49.8±18.1

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nurse Practitioners Critical in Treating Older Adults as Ranks of Geriatricians Shrink

Physician's Weekly

Ellen had been diagnosed with vascular dementia, peripheral vascular disease, and Type 2 diabetes. The Health Resources and Services Administration projects a 50% increase in demand for geriatricians from 2018 to 2030, when the entire baby boom generation will be older than 65.

article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

So, the question becomes, what, if anything, should we do differently in the primary care setting to diagnose the disease? We address the following questions with Nate: Has anything changed for the primary care doctor when diagnosing Alzheimers? So let’s just say you have a healthy 55 year old or 65 year old in your clinic.

article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

Praised by the FDA, Alzheimer’s Association (AA), and Pharma as a “game changer”, but derided by others for the drug’s lack of clinical efficacy, risk of severe adverse effects, absence of diversity in trial populations, high costs, and an FDA approval process that was in the kindest words “rife with irregularities”. That was an FDA decision.

article thumbnail

Keynote: Finding your bliss—beating physician “burnout”

Pamela Wible MD

Drawing from her experience running a physician suicide helpline , she speaks candidly about the emotional toll of assembly-line medicine , the link between overwork and doctor suicide , and the revolutionary joy of reclaiming your career by launching your own ideal clinic. I was in a big-box clinic. Does that make any sense at all?

Clinic 246
article thumbnail

A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity

Physician's Weekly

He was diagnosed as a baby with Prader-Willi syndrome — a rare disorder sparked by a genetic abnormality. Obesity medicine is likely heading the way of treatments for high blood pressure or diabetes, with three to five effective options for different types of patients. He continued to be disinterested in food for years.